BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2202127)

  • 1. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
    Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
    Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 5. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 7. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
    Gonwa TA; Nghiem DD; Corry RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
    [No Abstract]   [Full Text] [Related]  

  • 9. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
    Schweizer RT; Rovelli M; Roper L; Bartus SA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful cadaveric renal transplantation in infants and young children.
    Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple drug therapy: an alternative regimen in renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1920-1. PubMed ID: 3079059
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved immunosuppression for heart transplantation.
    Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine as treatment for corticosteroid-resistant rejection episodes in renal transplantation.
    Garcia VD; Goldani JC; Garcia CD; Cantisani GP; Losekann A; Messias A; Mattos DB; Vitola SP; Bianchini JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1643-5. PubMed ID: 2652537
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.